Related Experiment Video

Updated: May 12, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

DAPK1 modulates a curcumin-induced G2/M arrest and apoptosis by regulating STAT3, NF-κB, and caspase-3 activation

Bingshan Wu1, Hui Yao, Shanshan Wang

  • 1Affiliated Bayi Brain Hospital, Bayi Clinical College, Southern Medical University, Beijing, PR China.

Biochemical and Biophysical Research Communications
|April 3, 2013
PubMed

Insights

Curcumin enhances cancer cell death by increasing the expression of death-associated protein kinase 1 (DAPK1). This DAPK1 activation is crucial for curcumin

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Curcumin, a polyphenol from Curcuma longa, exhibits anti-cancer properties.
  • Tumor cell death pathways are critical targets for cancer therapy.

Purpose of the Study:

  • To investigate the role of death-associated protein kinase 1 (DAPK1) in curcumin's anti-carcinogenic effects.
  • To elucidate the molecular mechanisms underlying curcumin-induced tumor cell death.

Main Methods:

  • Assessing DAPK1 expression at mRNA and protein levels in U251 cells treated with curcumin.
  • Utilizing siRNA to knockdown DAPK1 and evaluating its impact on signaling pathways (STAT3, NF-κB) and apoptosis.
  • Analyzing curcumin-induced G2/M cell cycle arrest and apoptosis in the presence and absence of DAPK1.

Main Results:

  • Curcumin significantly increased DAPK1 expression in U251 cells.
  • DAPK1 knockdown attenuated curcumin's inhibition of STAT3 and NF-κB signaling pathways.
  • Suppression of DAPK1 diminished curcumin-induced caspase-3 activation, G2/M cell cycle arrest, and apoptosis.

Conclusions:

  • DAPK1 is a key mediator of curcumin's anti-cancer effects.
  • Curcumin exerts its tumor-suppressive functions through DAPK1-dependent pathways.
  • These findings suggest novel therapeutic strategies utilizing curcumin for cancer treatment.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...